Qube Research & Technologies (QRT)’s Atara Biotherapeutics ATRA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-102,663	Closed	-$873K	–	3297
2024 Q2	$873K	Buy	+102,663	New	+$1.54M	﹤0.01%	1956
2023 Q3	–	Sell	-1,396	Closed	-$56.2K	–	4081
2023 Q2	$56.2K	Buy	+1,396	New	+$78.9K	﹤0.01%	2059
2023 Q1	–	Sell	-2,240	Closed	-$184K	–	2527
2022 Q4	$184K	Buy	+2,240	New	+$233K	﹤0.01%	1849
2022 Q2	–	Sell	-947	Closed	-$220K	–	2478
2022 Q1	$220K	Buy	+947	New	+$302K	﹤0.01%	1915
2021 Q3	–	Sell	-784	Closed	-$305K	–	2190
2021 Q2	$305K	Sell	784 -2,488	-76%	-$887K	﹤0.01%	1571
2021 Q1	$1.18M	Buy	3,272 +1,463	+81%	+$647K	0.02%	786
2020 Q4	$888K	Buy	+1,809	New	+$835K	0.01%	912

Other funds holding ATRA

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ATRA Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Atara Biotherapeutics (ATRA) in Q3 2024, closing a stake of 102,663 shares — an estimated $873K sold.

Qube Research & Technologies (QRT) first reported a position in ATRA in Q4 2020 and held it in 7 quarters. The position peaked at $1.18M in Q1 2021. 35 funds tracked by Wall St. Rank hold ATRA as of Q3 2024.

Qube Research & Technologies (QRT) reported no remaining Atara Biotherapeutics position as of Q3 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 102,663 Atara Biotherapeutics shares in Q3 2024, an estimated $873K.
Qube Research & Technologies (QRT) first reported a position in Atara Biotherapeutics in Q4 2020 and held it in 7 quarters.
Qube Research & Technologies (QRT)'s Atara Biotherapeutics position peaked at $1.18M in Q1 2021.
35 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.